title: Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia.
authors.forename: A
authors.initials: A
authors.lastname: Takeshita
authors.forename: A
authors.initials: A
authors.lastname: Uehara
authors.forename: K
authors.initials: K
authors.lastname: Shinjo
authors.forename: K
authors.initials: K
authors.lastname: Naito
authors.forename: N
authors.initials: N
authors.lastname: Sahara
authors.forename: K
authors.initials: K
authors.lastname: Yamazaki
authors.forename: H
authors.initials: H
authors.lastname: Katoh
authors.forename: T
authors.initials: T
authors.lastname: Kamikawa
authors.forename: K
authors.initials: K
authors.lastname: Ohnishi
authors.forename: M
authors.initials: M
authors.lastname: Maekawa
authors.forename: H
authors.initials: H
authors.lastname: Hayashi
authors.forename: R
authors.initials: R
authors.lastname: Ohno
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D010087:Oxides / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide